Josh Oglesbee

Drive sales of Zenrelef to C-Suites, OR Directors, Directors of Pharmacy, Materials Management, and Surgeons, including Orthopedics, General Surgery, OB/GYN, Plastic, Cardiothoracic, and Anesthesia. Product is in launch phase, providing 72-hour postsurgical analgesia in adults after surgical procedures.

Responsible for sales growth of Exparel, a unique drug delivery system extending post surgical anesthesia by administering multivesicular liposomal encapsulated Bupivacaine for post surgical pain control over several days. Surgical specialties include, Plastic, Vascular, General, Orthopedic, Trauma, Reconstructive, OBGYN, and others. Currently manage 4 Divisions of DePuy Managers and their Representatives, coaching, educating, and managing in the O.R. on Exparel collaborations. Key Accomplishments: ? Took over a territory doing 200k in sales growing to current $ 2.5 million / year ? Finished in the Top 15 my first year of employment ? Currently rank the Top 20th Territory out of 98 territories ? 2019 Box Sales of 868 vs 671 in 2018 ? Selected to the Outpatient Reimbursement Task Force Team for Pacira in 2019